Hong Kong Stock News

JW (Cayman) Therapeutics came into this earnings print as a cheap revenue story, trading on a P/S ratio below both Hong Kong biotech peers and the wider sector, with the stock up 42.4% over the past month. The headline this half is not the share price. It is the sharp compression in reported losses. H1 2026 revenue reached ¥111.4 million, while the company cut its net loss to ¥50.4 million and basic earnings per share loss to ¥0.12. For a still unprofitable cell therapy developer, that scale...

Guangdong Tianyu Semiconductor stock closed at HK$38.30, roughly flat over the past week after a weak three month stretch. The market reaction looks calm, yet the headline from H1 2026 is anything but. Revenue reached ¥347.9m, while the company swung from a small H1 2025 profit to a loss of ¥119.8m and basic earnings per share of ¥0.30 in the red. The short term story is a profit squeeze. The longer term story is whether forecast revenue growth and a potential path back to profitability can...

Tian Tu Capital stock has been drifting lower in recent weeks, yet the latest quarter delivered a very different message. Q2 2026 showed Total Revenue of C¥267.3 million and Net Income of C¥147.3 million, which sits against a trailing P/E of 6.1x that still prices in plenty of scepticism. The headline here is simple: a volatile Hong Kong capital markets stock that recently returned to profitability has just reported another profitable quarter. The full story now turns on how durable this...

Shanghai Chicmax Cosmetic closed at HK$22.52 after a tough run, with the stock down about 38% over the past three months. Yet the latest half year earnings tell a different story from the share price slide. Revenue for the first half of 2026 came in at CNY 3,756.5m, while basic earnings per share were CNY 0.27, which puts fresh focus on profitability rather than top line scale. The real headline is margin pressure. Trailing net profit margin is now 7.8% compared with 12.2% a year earlier...

Shenzhen Investment just closed at HK$0.70, with the stock drifting over the past week, while the new half year numbers point to a deeper issue that goes beyond a soft share price. The key story is not revenue; it is the scale and persistence of losses. Basic earnings per share for the first half came in negative again, and net income stayed firmly in the red. For a highly leveraged property developer, that loss trend and weak interest coverage are what really challenge the bullish case, no...

China Life Insurance stock went into this earnings print already grinding higher, with steady gains over the past week and month. Yet the real story sat in the profit engine. Net income for Q2 landed at ¥114,984m on revenue of ¥189,561m, reinforcing a wide earnings cushion for a life insurer that investors often value on consistency and capital strength. The headline for today is simple. China Life Insurance is generating substantial profits while trading on a P/E of 2.9x that is well below...

Transtech Optelecom Science Holdings has been trading like a turnaround story, with the stock up about 73% over the past three months and roughly 59% over the past month. However, the latest move into earnings was slightly softer, with a 7 day decline. The new H1 2026 numbers show why the story is so polarising. Revenue sits at HK$143.4m and basic earnings per share hit HK$0.142, but the trailing 12 month figures still point to a loss, and a high price to sales multiple of 15.8x keeps...

Kindstar Globalgene Technology stock closed at HK$0.97 after a mixed stretch for shareholders, with a small gain over the past month and a weaker 90 day run. The market is reacting to one core message in these H1 2026 results: losses continue, yet the earnings drag is easing while revenue holds close to recent levels. The real story now sits beyond today’s tick-by-tick action. Trailing 12 month revenue is C¥950.3m and the loss from continuing operations is C¥40.6m, which is smaller than in...

Wasion Holdings closed at HK$15.41 after a rough three months where the stock gave up almost 29%. That kind of slide hints at investors bracing for an earnings stumble. Instead, H1 2026 landed with a clean headline. Revenue came in at ¥5,389.4m and basic earnings per share were ¥0.444, broadly in line with the recent run rate. The real tension today is psychological. The market has been pricing in trouble, while trailing twelve month earnings growth and a 13x P/E against richer peers point to...

A Living Smart City Services stock has been grinding lower, with the share price down about 21% over the past three months and closing at HK$1.845 just after the latest results. The headline this half is profit repair. The company swung back to a net profit of CNY 316.83m in H1 2026 after a loss in H2 2025, even though revenue sat at CNY 6,063.59m. For a property services player often viewed as a yield story, that earnings rebound against a weak recent share price sets up a sharp debate about...

The market has kept MIXUE Group on a short leash, with the stock down about 9% over the past week and nearly 20% over three months even after the latest earnings release. Yet the headline from these results is not about a collapse in demand. The key story is a squeeze on profitability, with trailing net margin at 16.2% compared with 18.1% a year earlier and earnings growth over the past year running well below the five year pace. Short term traders reacted to fading momentum. Longer term...

Shanghai Able Digital Science&Tech closed at HK$311 after a 30 day surge that left the stock far ahead of the wider Hong Kong market. The fresh H1 2026 numbers tell a cooler story. Revenue reached ¥327.9m while the company swung back into a loss with basic earnings per share of ¥1.75. The market is still paying a rich 17.4x trailing P/S, which keeps the spotlight firmly on how much of the recent enthusiasm reflects emotion rather than comfort with these compressed margins and profit...

Yeahka walked into this earnings release with the stock under pressure, down over 16% in the past three months, and trading on a premium P/E of 19.4x versus the broader Asian diversified financials. The market has been paying up for the story of fast growth and improving economics. The headline from H1 2026 is that management leaned hard into profit quality instead of raw volume, with revenue of RMB 1,249.2m and net income of RMB 43.9m, while also declaring the company’s first interim...

CaoCao came into this earnings print with a bruised share price over the past quarter, yet the stock closed at HK$14.29 as investors weighed a familiar trade off. The market still prices CaoCao like a struggling ride hailing platform, while the latest half year numbers show a business lifting revenue to ¥10.34b but still posting a net loss of ¥380.83m. The real story this time is the balance sheet. The company continues to run with negative shareholders’ equity, which keeps financial risk...

Aluminum Corporation of China just printed another heavy quarter while the stock barely flinched. The shares closed at HK$8.77 on 28 August, roughly flat over the past month and still down about 20% over three months, even as earnings power tracks higher. The headline this time is profitability. Q2 basic earnings per share came in at ¥0.37 with net income excluding extra items of ¥6.34b and trailing net margin holding around 7%. For a stock on a 7.4x P/E and trading well below some value...

HBM Holdings closed at HK$15.08 after the market had a full day to process its half year numbers. The stock has cooled over the past week but is still up strongly over the past month, which matters when you look at what these results actually say. The headline is not revenue or earnings per share; the story is margin pressure, with trailing net profit margin at 47.2% compared with 63.1% a year ago, while the stock trades on a P/E of 19.8x and above a discounted cash flow value of...

China High Speed Transmission Equipment Group came into this earnings day with a stock that had slipped about 9% over both the past week and past month, while trading on a low trailing P/E of 3.9x compared with much higher industry averages. The market has been pricing in doubt. The H1 2026 report instead puts the spotlight on profitability, with basic earnings per share of CN¥0.02 and net income of CN¥32.9m, and a trailing twelve month net income of CN¥380.2m after a period that included a...

Wynn Macau entered this earnings season with a casino recovery story and a stock that has drifted, down over the past week and roughly flat over three months, and then closed today at HK$5.70. The twist is that the latest half year showed solid profitability, with basic earnings per share at HK$0.30 and net income of HK$1,546.4m. The headline is less about a rebound in the share price and more about whether this level of earnings strength, on a P/E of about 10x, really aligns with a balance...

Morimatsu International Holdings finished today at HK$7.55, with the stock roughly flat over the past week after a weak 90 day stretch. That calm surface hides a sharp earnings jolt. The latest half year numbers show revenue of C¥2,572.9m but the company swung to a loss of C¥143.6m and basic earnings per share slipped into a C¥0.12 loss. For a stock already trading on a high trailing P/E multiple compared with Hong Kong machinery peers, this profit squeeze is the headline investors now have...

Biocytogen Pharmaceuticals (Beijing) closed at HK$61.25 after a choppy few weeks, with the stock down 5.8% over 7 days but still up double digits over 1 and 3 months. The earnings story that hit the tape today focused on profit power. Quarterly basic earnings per share came in at ¥0.31 with net income of ¥137.06m, reinforcing a trailing net margin of 21.6%. The market now has to decide whether that profit profile justifies a 64.1x trailing P/E in a volatile biotech stock. Love Biocytogen...

Zhongyu Energy Holdings closed at HK$2.55 after earnings, with the stock roughly flat over the past month, yet the new numbers tell a more charged story. The headline is a sharp swing in profitability, with basic earnings per share for the first half of 2026 at HK$0.0827 and net income from ordinary operations at HK$226.2m. For a gas utility that has struggled with a multi year earnings decline and tight interest coverage, this rebound in profit quality is the data point that matters. The...

Shui On Land shares closed at HK$0.465 after a mixed few months, with the stock up over the past week but down over the past quarter. The headline number this time is simple. The company swung back to profit in the first half of 2026, with basic earnings per share of ¥0.027843 and net income of ¥223 million. The near term relief is clear. The deeper story is harder. Over the past 12 months Shui On Land still reported a sizeable loss and earnings did not cover interest costs, so the real...

Modern Dental Group’s share price barely moved over the past week, yet the latest half year numbers land with far more force than the price action suggests. The market is treating this stock like just another mid cap healthcare play. The earnings tell a different story built around profitability and value. The headline is simple: Modern Dental Group reported solid H1 2026 earnings, with basic earnings per share of HK$0.4007 and trailing net profit margin at 17.4%. At a P/E of 11.2x against...

China Electronics Huada Technology closed at HK$0.895 after the market digested its first half 2026 earnings, a stock that has already slipped over the past three months. The headline is simple: profitability held up better than the share price suggests, with basic earnings per share at HK$0.0616 and net income from ordinary operations at HK$125.0m on revenue of HK$1,170.6m. The real tension for you as an investor sits between that earnings resilience and a low 8.2x P/E alongside a discounted...